No Data
AstraZeneca (AZN) Gets a Sell From Deutsche Bank
AstraZeneca Says Obesity Pill Well Tolerated by Type-2 Diabetes Patients, Competitive
AstraZeneca's Promising Obesity Treatment Advances Justify Buy Rating: Analyst Report
US stocks closed: Trump, Harris concept stocks rose together, Chinese concept stocks remained stable and rose.
1. The market is filled with a wait-and-see attitude, with all three major indexes collectively falling. 2. Trump's media technology group rebounded after hitting bottom. 3. Photovoltaic and clean energy concept stocks strengthened collectively. 4. Reports claim that Nvidia will distribute Super Micro Computer orders to other suppliers.
UBS Reaffirms Their Sell Rating on AstraZeneca (AZN)
Sector Update: Health Care Stocks Softer in Afternoon Trading
PaulG : 22 00
103704651 OP PaulG : 22 above today